Mitosis Counting

  • C. M. Quinn
  • N. A. Wright


It is a truism to say that the main (nay, only) method of assessing cell proliferation which has enjoyed any routine popularity has been the assessment of mitotic activity. This is obviously because nothing special has to be done to the tissues (indeed routine sections are usually used). However, instead of approaching such measurements on an appropriate basis, i.e. achieving measurements of accuracy and known precision, most workers have relied on easy, non-critical, rule-of-thumb assessments. Such an approach is, in our opinion, a perfect recipe for disaster. In this chapter we review the several methods of assessing mitotic activity, the purported role of these measurements in prognosis, and reflect on the vagaries of these measurements.


Mitotic Index Mitotic Count Smooth Muscle Tumour Endometrial Stromal Sarcoma Placental Site Trophoblastic Tumour 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aherne WA, Camplejohn RS and Wright NA (1977a) An introduction to cell population kinetics. Edward Arnold, LondonGoogle Scholar
  2. Aherne WA, Al-Wiswazy M, Ford D and Kellerer AM (1977b) Assessment of inherent fluctuations of mitotic and labelling indices of human tumours. Br J Cancer 36:577–591PubMedCrossRefGoogle Scholar
  3. Akerman M, Brandt L, Johnson A and Olsson H (1987) Mitotic activity in non-Hodgkin’s lymphoma. Relation to the Kiel classification and to prognosis. Br J Cancer 55:219–223PubMedCrossRefGoogle Scholar
  4. Appelman HD and Helwig EB (1976) Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma). Cancer 38:709–728CrossRefGoogle Scholar
  5. Appelman HD and Helwig EB (1977) Cellular leiomyomas of the stomach in 49 patients. Arch Pathol Lab Med 101:373–377PubMedGoogle Scholar
  6. Baak JPA (1990) Mitosis counting in tumors. Hum Pathol 21:683–685PubMedCrossRefGoogle Scholar
  7. Baak JP, Lindeman J, Overdiep SH and Langley FA (1982) Disagreement of histopathological diagnoses of different pathologists in ovarian tumors - with some theoretical considerations. Eur J Obstet Gynecol Reprod Biol 13:51–55PubMedCrossRefGoogle Scholar
  8. Baak JP, Langley FA, Talerman A and Delemarre JF (1986) Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing. Anal Quant Cytol Histol 8:354–357PubMedGoogle Scholar
  9. Baak JP, Wisse Brekelmans EC, Uyterlinde AM and Schipper NW (1987) Evaluation of the prognostic value of morphometric features and cellular DNA content in FIGO I ovarian cancer patients. Anal Quant Histol Cytol 9:287–290Google Scholar
  10. Baak JPA, Schipper NW, Wisse-Brekelmans ECM et al. (1988) The prognostic value of morphometrical features and cellular DNA content in cisplatin treated late ovarian cancer patients. Br J Cancer 57:503–508PubMedCrossRefGoogle Scholar
  11. Baak JPA, van Diest PJ and Ariens ATH, et al. The multicenter morphometric mammary carcinoma project (1989) A nationwide prospective study on reproducibility and prognostic power of routine quantitive assessments in the Netherlands. Pathol Res Pract 185:664–670PubMedCrossRefGoogle Scholar
  12. Bell DA, Weinstock MA and Scully RE (1988) Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer 62:2212–2222PubMedCrossRefGoogle Scholar
  13. Bennett MH, Farrer-Brown G, Henry K and Jelliffe JM (1974) Classification of non Hodgkins lymphoma. Lancet ii:405–406CrossRefGoogle Scholar
  14. Bucsema J, Carpenter SE, Rosenshein NB and Woodruff JD (1986) Epithelioid leiomyosarcoma of the uterus. Cancer 57:1192–1196CrossRefGoogle Scholar
  15. Burns B, Curry RH and Bell MEA (1979) Morphological features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases. Am J Obstet Gynecol 135:109–114PubMedGoogle Scholar
  16. Busch CH and Vasko J (1988) Differential staining of mitoses in tissue sections and cultured cells by a modified methenamine silver method. Lab Invest 59:876–878PubMedGoogle Scholar
  17. Camplejohn RS, Bone G and Aherne WA (1973) Cell proliferation in rectal carcinoma and rectal mucosa. A stathmokinetic study. Eur J Cancer 9:577–581PubMedGoogle Scholar
  18. Christopherson WM, Williamson EO and Gray LA (1972) Leiomyosarcoma of the uterus. Cancer 29:1512–1517PubMedCrossRefGoogle Scholar
  19. De Potter CR, Praet MM, Slavin RE, Verbeeck P and Roels HJ (1987) Feulgen DNA content and mitotic activity in proliferative breast disease. A comparison with ductal carcinoma in situ. Histopathology 11:1307–1319PubMedCrossRefGoogle Scholar
  20. De Fusco PA, Gaffey TA, Malkasian GD, Long HJ and Cha SS (1989) Endometrial stromal sarcoma: review of Mayo Clinic experience 1945–1980. Gynecol Oncol 35:8–14PubMedCrossRefGoogle Scholar
  21. Donhuijsen K (1986) Mitosis counts. Reproducibility and significance in grading of malignancy. Hum Pathol 17:1122–1125PubMedCrossRefGoogle Scholar
  22. Donhuijsen K (1987) Mitoses in non Hodgkin’s lymphoma. Frequency and prognostic relevance. Pathol Res Pract 182:352–357PubMedCrossRefGoogle Scholar
  23. Donhuijsen K, Schmidt U, Hirche H, van Beunningen D and Budach V (1990) Changes in mitotic rate and cell cycle fractions caused by delayed fixation. Hum Pathol 21:709–714PubMedCrossRefGoogle Scholar
  24. Duffill M, Wright N and Shuster S (1976) The cell proliferation kinetics of psoriasis examined by three in vivo techniques. Br J Dermatol 94:355–362PubMedCrossRefGoogle Scholar
  25. Eckstein RP, Paradinas RF and Bagshawe KD (1982) Placental site trophoblastic tumor: a study of four cases requiring hysterectomy including one fatal case. Histopathology 6:211–226PubMedCrossRefGoogle Scholar
  26. Eckstein RP, Russell P, Friedlander ML, Tattersall MHN and Bradfield A (1985) Metastasising placental site trophoblastic tumor: a case study. Hum Pathol 16:632–636PubMedCrossRefGoogle Scholar
  27. Edwards JL and Donalson JT (1964) The time of fixation and the mitotic index. Am J Clin Pathol 41:158–162PubMedGoogle Scholar
  28. Ellis PSJ and Whitehead R (1981) Mitosis counting - a need for reappraisal. Hum Pathol 12:3–4PubMedCrossRefGoogle Scholar
  29. Evans HL (1982) Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50:2170–2182PubMedCrossRefGoogle Scholar
  30. Evans HL (1985) Spiooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years. Cancer 56:2242–2250PubMedCrossRefGoogle Scholar
  31. Evans HL, Butler J J and Youness EL (1978) Malignant lymphoma, small lymphocytic type. A clinicopathologic study of 84 cases with suggested criteria for intermediate lymphocytic lymphoma. Cancer 41:1440–1455PubMedCrossRefGoogle Scholar
  32. Friedlander ML (1984) Prognostic variables in epithelial ovarian cancer: A review. Aust NZ Obstet Gynecol 24:256–261CrossRefGoogle Scholar
  33. Fu YS, Huang I and Beaudenon S et al. (1988) Correlative study of human papillomavirus DNA, histopathology, and morphometry in cervical condyloma and intraepithelial neoplasia. Int J Gynecol Pathol 7:297–307PubMedCrossRefGoogle Scholar
  34. Gallup DG and Corday DR (1979) Leiomyosarcoma of the uterus: Case reports and a review. Obstet Gynecol Surv 34:300–312PubMedCrossRefGoogle Scholar
  35. Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld AG and van Unnik JAM (1974) Classification of Non Hodgkin’s lymphoma. Lancet ii:406–408Google Scholar
  36. Gitstein S, Baratz M, David MP and Toaf R (1980) Endometrial stromatosis of uterus. A clinicopathological study of five cases. Gynecol Oncol 9:23–30PubMedCrossRefGoogle Scholar
  37. Gloor E, Dialdes J, Hurlimann J, Ribolze J and Barrelet L (1983) Placental site trophoblastic tumor of the uterus with metastases and fatal outcome. Clinical and autopsy observations of a case. Am J Surg Pathol 7:483–486PubMedCrossRefGoogle Scholar
  38. Graem N and Helweg-Larsen K (1979) Mitotic activity and delay in fixation of tumour tissue. Acta Pathol Microbiol Scand Sect A 87:375–378Google Scholar
  39. Griffin NR, Howard MR, Quirke P, O’Brien CJ, Child JA and Bird CC (1988) Prognostic indicators in centroblastic centrocytic lymphoma. J Clin Pathol 41:866–870PubMedCrossRefGoogle Scholar
  40. Haapasalo H, Collan Y, Atkin NB, Pesonen E and Seppa A (1989a) Prognosis of ovarian carcinomas: prediction by histoquantitative methods. Histopathology 15:167–178PubMedCrossRefGoogle Scholar
  41. Haapsalo H, Pesonen E and Collan Y (1989b) Volume corrected mitotic index (M/V index) – the standard of mitotic activity in neoplasms. Pathol Res Pract 185:551–554Google Scholar
  42. Haapasalo H, Collan Y, Seppa, Gidlund AL, Atkin NB and Pesonen E (1990) Prognostic value of ovarian carcinoma grading methods - a method comparison study. Histopathology 16:1–7PubMedCrossRefGoogle Scholar
  43. Hacker NF, Berek JS, Lagasse LD, Nieberg RK and Elashoff RM (1983) Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 61:413–420PubMedGoogle Scholar
  44. Hannigan EV and Gomez LG (1979) Uterine leiomyosarcoma. A review of prognostic clinical and pathologic features. Am J Obstet Gynecol 134:557–564PubMedGoogle Scholar
  45. Hart WR and Billman JK (1978) A reassessment of uterine neoplasms originally diagnosed as leiomyosarcomas. Cancer 41:1902–1910PubMedCrossRefGoogle Scholar
  46. Hemdal I and Frankendal B (1985) Letter to editor. (Comment on paper by Marchesse et al.) Gynecol Oncol 22:379–380PubMedCrossRefGoogle Scholar
  47. Hermens AF and Barendsen GW (1969) Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after X-irradiation. Eur J Cancer 5:173–189PubMedGoogle Scholar
  48. Kempson RL (1976) Mitosis counting II. Hum Pathol 7:482–483PubMedCrossRefGoogle Scholar
  49. Kempson RL and Bari W (1970) Uterine sarcomas. Classification, diagnosis and prognosis. Hum Pathol 1:331–349PubMedCrossRefGoogle Scholar
  50. King ME, Dickerson GR and Scully RE (1982) Myxoid leiomyosarcoma of the uterus. A report of six cases. Am J Surg Pathol 6:589–598PubMedCrossRefGoogle Scholar
  51. Kurman RJ and Norris HJ (1976) Mesenchymal tumors of the uterus. VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear cell leiomyoma. A clinical and pathological analysis of twenty-six cases. Cancer 37:1853–1865PubMedCrossRefGoogle Scholar
  52. Kurman RJ, Scully RE and Norris HJ (1976) Trophoblastic pseudotumor of the uterus. Cancer 38:1214–1226PubMedCrossRefGoogle Scholar
  53. Lathrop JC, Lauchlan S, Nayak R and Ambler M (1988) Clinical characteristics of placental site trophoblastic tumor (PSTT). Gynecol Oncol 31:32–42Google Scholar
  54. Lipponen PK, Eskelinen M, Collan Y, Marin S and Alhara E (1990a) Volume-corrected mitotic index in human pancreatic cancer: relation to histological grade, clinical stage and prognosis. Scand J Gastroenterol 25:548–554PubMedCrossRefGoogle Scholar
  55. Lipponen PK, Collan Y, Eskelinen M, Pesonen E and Sotarauta M (1990b) Volume-corrected mitotic (M/V index) in human bladder cancer: relation to histological grade (WHO), clinical stage (UICC) and prognosis. Scand J Urol Nephrol 24:39–45PubMedCrossRefGoogle Scholar
  56. Malkasian GD, Melton J, O’Brien PC and Greene MH (1984) Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary. Am J Obstet Gynecol 149: 274–284PubMedGoogle Scholar
  57. Marchesse MJ, Liskow AS, Crum CP, McCaffrey RM and Frick HC (1984) Uterine sarcomas: a clinicopathologic study, 1965–1981. Gynecol Oncol 18:299–312CrossRefGoogle Scholar
  58. Morimoto N, Ozawa M, Kato Y and Kuramoto H (1982) Diagnostic value of mitotic activity in endometrial stromal sarcoma. Report of two cases. Acta Cytologica 26:695–704PubMedGoogle Scholar
  59. Norris HJ (1976) Mitosis counting III. Hum Pathol 7:483–484PubMedCrossRefGoogle Scholar
  60. Norris HJ and Taylor HB (1966) Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 19:755–766PubMedCrossRefGoogle Scholar
  61. Perrone T and Dehner LP (1988) Prognostically favourable “mitotically active” smooth muscle tumors of the uterus. A clinicopathologic study of ten cases. Am J Surg Pathol 12:1–8PubMedCrossRefGoogle Scholar
  62. Piver MS, Rutledge FN, Copeland L, Webster K, Blumenson L and Suh O (1984) Uterine endolymphatic stromal myosis: a collaborative study. Obstet Gynecol 64:173–178PubMedCrossRefGoogle Scholar
  63. Quinn CM and Wright NA (1990) The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 160:93–102PubMedCrossRefGoogle Scholar
  64. Ralfs I, Dawber R, Ryan T, Duffill M and Wright NA (1981) The kinetics of metaphase arrest in human psoriatic epidermis; an examination of optimal experimental conditions for determining the birth rate. Br J Dermatol 104:231–242PubMedCrossRefGoogle Scholar
  65. Ranchod M and Kempson RL (1977) Smooth muscle tumors of the gastrointestinal tract and retroperitoneum. A pathologic analysis of 100 cases. Cancer 39:255–262PubMedCrossRefGoogle Scholar
  66. Rappaport H (1966) Tumors of the haematopoietic system. In: Atlas of tumor pathology. Armed Forces Institute of Pathology Washington DCGoogle Scholar
  67. Richardson GS, Scully RE, Nikrui N and Nelson JH (1985) Common epithelial cancer of the ovary (first of two parts). N Engl J Med 312:415–424PubMedCrossRefGoogle Scholar
  68. Rodenburg CJ, Cornelisse CJ, Hermans J and Fleuren GJ (1988) DNA flow cytometry and morphometry as prognostic indicators in advanced ovarian cancer: A step forward in predicting the clinical outcome. Gynecol Oncol 29:176–187PubMedCrossRefGoogle Scholar
  69. Ronan SG, Han MC and Das Gupta TK (1988) Histologic indicators in cutaneous malignant melanoma. Semin Oncol 15:558–565PubMedGoogle Scholar
  70. Sadler DW and Coghill SB (1989) Histopathologists, malignancies and undefined high power fields. Lancet i:785–786CrossRefGoogle Scholar
  71. Saksela E, Lampijien V and Procope BJ (1974) Malignant mesenchymal tumors of the uterine corpus. Am J Obstet Gynecol 120:452–460PubMedGoogle Scholar
  72. Scully RE and Young RH (1981) Trophoblastic pseudotumor. A reappraisal. Am J Surg Pathol 5:75–76CrossRefGoogle Scholar
  73. Silverberg SG (1971) Leiomyosarcoma of the uterus. A clinicopathologic study. Obstet Gynecol 38:613–628PubMedCrossRefGoogle Scholar
  74. Silverberg SG (1976) Reproducibility of the mitosis count in the histologic diagnosis of smooth muscle tumors of the uterus. Hum Pathol 7:451–454PubMedCrossRefGoogle Scholar
  75. Simnett JD and Heppleston AG (1966) Cell renewal in the mouse lung. The influence of sex, strain and age. Lab Invest 15:1793–1801PubMedGoogle Scholar
  76. Sorbe B, Frankendal B and Veress B (1982) Importance of histologic grading in the prognosis of epithelial ovarian carcinoma. Obstet Gynecol 59:576–582PubMedGoogle Scholar
  77. Stansfeld AG, Diebold J and Noel H, et al. (1988) Updated Kiel classification for lymphomas. Lancet i:292–293CrossRefGoogle Scholar
  78. Start RD, Cross SS and Smith JFH (1990) Effect of delayed fixation in the assessment of tumour cell proliferation. J Pathol 161:183–184PubMedCrossRefGoogle Scholar
  79. Swerdlow SH, Habeshaw JA, Dhaliwall HS, Lister TA and Stansfeld AG (1983) Centrocyte lymphoma: a distinct clinicopathologic and clinical entity. Am J Pathol 113:181–197PubMedGoogle Scholar
  80. Taina E, Maenpaa J, Erkkola R, Ikkala J, Soderstrom O and Viitanen A (1989) Endometrial stromal sarcoma: a report of nine cases. Gynecol Oncol 32:156–162PubMedCrossRefGoogle Scholar
  81. Tannock IF (1968) The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer 22:258–273PubMedCrossRefGoogle Scholar
  82. Tannock IF (1970) Population kinetics of carcinoma cells, capillary endothelial cells and fibroblasts in a transplanted mouse mammary tumor. Cancer Res 30:2470–2476PubMedGoogle Scholar
  83. Taylor HB and Norris HJ (1966) Mesenchymal tumors of the uterus. IV. Diagnosis and prognosis of leiomyosarcomas. Arch Pathol 82:40–44PubMedGoogle Scholar
  84. Taylor JF, Iversen OH and Bjerknes R (1977) Growth kinetics of Kaposi’s sarcoma. Br J Cancer 35:470–478PubMedCrossRefGoogle Scholar
  85. Thatcher SS and Woodruff JD (1982) Uterine stromatosis: a report of 33 cases. Obstet Gynecol 59:428–434PubMedGoogle Scholar
  86. The Non-Hodgkin’s lymphoma pathologic classification project: National Cancer Institute sponsored study of classifications of Non-Hodgkin’s lymphoma (1982) Summary and description of a working formulation for clinical usage. Cancer 49:2112–2135CrossRefGoogle Scholar
  87. Tiltman AJ (1988) Muscle tumor mitoses. Am J Surg Pathol 12:967–968PubMedGoogle Scholar
  88. Twiggs LB, Okagaki T, Phillips GL, Stroemer JR and Adcock LL (1981) Trophoblastic pseudotumor-evMence of malignant disease potential. Gynecol Oncol 12:238–248PubMedCrossRefGoogle Scholar
  89. Wright NA (1984) Cell proliferation in health and disease. In: Anthony PP, MacSween RNM (eds) Recent advances in histopathology. Churchill Livingstone, Edinburgh, pp 17–33Google Scholar
  90. Wright NA and Alison M (1984) The biology of epithelial cell populations. Clarendon Press, OxfordGoogle Scholar
  91. Wright NA and Appleton DR (1980) The metaphase arrest technique. A critical review. Cell Tissue Kinet 13:643–663PubMedGoogle Scholar
  92. Wright NA, Britton DC, Bone G and Appleton DR (1977) An in vivo stathmokinetic study of cell proliferation in human gastric carcinoma and gastric mucosa. Cell Tissue Kinet 10:429–438PubMedGoogle Scholar
  93. Wright NA, Appleton DR, Marks J and Watson AJ (1979) Cytokinetic studies of crypts in convoluted human small intestinal mucosa. J Clin Pathol 32:462–470PubMedCrossRefGoogle Scholar
  94. Yoonessi M and Hart WR (1977) Endometrial stromal sarcomas. Cancer 40:898–906PubMedCrossRefGoogle Scholar
  95. Young RH and Scully RE (1984) Placental site trophoblastic tumor: current status. Clin Obstet Gynecol 27:248–258PubMedCrossRefGoogle Scholar
  96. Zaloudek C and Norris HJ (1987) Mesenchymal tumors of the uterus. In: Kurman RJ (ed). Blaustein’s pathology of the female genital tract. Springer Verlag, New York, pp 373–408CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1992

Authors and Affiliations

  • C. M. Quinn
  • N. A. Wright

There are no affiliations available

Personalised recommendations